Matthew C. Trudeau - US grants
Affiliations: | Neuroscience | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Neuroscience Biology, General Biophysics, Physiology BiologyWe are testing a new system for linking grants to scientists.
The funding information displayed below comes from the NIH Research Portfolio Online Reporting Tools and the NSF Award Database.The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please sign in and mark grants as correct or incorrect matches.
High-probability grants
According to our matching algorithm, Matthew C. Trudeau is the likely recipient of the following grants.Years | Recipients | Code | Title / Keywords | Matching score |
---|---|---|---|---|
2009 — 2014 | Trudeau, Matthew C | R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Molecular Physiology of Herg (Kcnh2) Pottasium Channels @ University of Maryland Baltimore DESCRIPTION (provided by applicant): Human ether a go-go-related gene 1a (HERG1a, Kv11.1) K+ channels play a critical role in maintaining the fundamental cardiac rhythm. The significance of HERG1a channels is that they are the central component of the rapid delayed-rectifier K+ channel (IKr) in heart. HERG and IKr are specialized to conduct an outward K+ current that drives repolarization of the late phase of the cardiac action potential. The critical role of HERG1a in health and disease is emphasized by inherited mutations in the gene encoding HERG channels. Mutations in HERG are associated with the long QT syndrome (LQTS) a cardiac disorder that causes arrhythmia, syncope and sudden death. HERG channels are of additional significance as a side-effect of an increasing number of pharmaceuticals is to produce an acquired form of LQTS (aLQTS) by inhibiting the function of HERG channels. The opening and closing (gating) of HERG and IKr channels are critical for normal cardiac electrophysiology and the normal heartbeat. In particular, the closing rate of native IKr channels is vital for the perfect timing of the outward IKr current during repolarization. Some advances, including our previous work, have delineated key molecular components of the channel closing (deactivation) mechanism, including two critical domains within the HERG1a N-terminal region. These are the `PAS'domain and a short region upstream here termed the PAS-CAP. Diversity in the mechanism of deactivation comes from a HERG1a variant, HERG1b that lacks the key PAS and PAS-CAP domains and consequently closes much faster than HERG1a. The presence of HERG1b in heart may explain the faster kinetics of deactivation measured for IKr. Despite these advances, a mechanism for channel deactivation has remained elusive. The goals of the proposed experiments are to determine a comprehensive molecular mechanism for closing in HERG and IKr. The Specific Aims are to 1) test the hypothesis that the PAS-CAP region determines deactivation gating via an electrostatic interaction with the channel 2) to test the hypothesis that the hydrophobic surface of the PAS domain interacts with a hydrophobic `PAS receptor site'in the channel to mediate deactivation and 3) to test the hypothesis that the HERG1b subunit is a key functional component of native IKr and that ERG1b accounts for the faster kinetics described for native IKr. To carry out the specific aims we will use a multidisciplinary approach that includes patch-clamp and voltage-clamp electrophysiology in heterologous expression systems and native cells, fluorescence spectroscopy, gene transfer to myocytes and native cell culture techniques. Our long-term objectives are to determine the fundamental molecular basis of gating and modulation in cardiac IKr channels, in an effort to better treat inherited LQTS and prevent acquired LQTS. |
0.972 |
2014 — 2021 | Meredith, Andrea L (co-PI) [⬀] Trudeau, Matthew C |
T32Activity Code Description: To enable institutions to make National Research Service Awards to individuals selected by them for predoctoral and postdoctoral research training in specified shortage areas. |
Training Program in Integrative Membrane Biology @ University of Maryland Baltimore Project Summary: The Training Program in Integrative Membrane Biology (TPIMB) is designed to train pre-doctoral students in the biology, biophysics, and physiology of biological membranes. Now in its 4th decade, the TPIMB continues to lead the effort in interdisciplinary training at the interface of molecular, cell, and systems biology at the University of Maryland School of Medicine (UMSOM), by focusing on the role of the cell membrane and intracellular membranes in mediating and integrating the functions of cells and their interactions with the environment. The program is guided by the idea that studies of membrane biophysics and physiology, and of membrane-based signaling cascades, can provide unique insights into the biology of cells and tissues, in both healthy and diseased states. The faculty of the TPIMB, numbering 39 individuals, are well-funded, highly interactive, and devoted to mentoring students studying a broad range of subjects related to membrane biology. Mentors are selected for their interests, extramural support, and commitment to mentoring. Trainees are selected based on their interests, graduate course grades, recommendations, and previous research experience. Requirements are a core course on Mechanisms in Biomedical Sciences, as well as a year-long class in research ethics, both of which are common to all laboratory research-based graduate education at the UMSOM. Trainees are also required to take a series of specialized upper level courses in membrane biochemistry, biophysics, links between membrane defects and human diseases, biostatistics, hypothesis testing and experimental design. They may also take electives in cellular and systems physiology, pharmacology, or neuroscience. Trainees participate regularly in student-oriented activities, such as a student seminar series, monthly get-togethers, and an annual retreat. The UMSOM supports this program generously through contributions to faculty salary, additional stipends for students, and funds for the TPIMB's regular activities. Current NIH/NIGMS funding supports 7 trainees, but this leaves many students following our curriculum and taking part in our activities without direct support. We enjoy a strong partnership with other NIGMS-supported programs at the UMSOM including the Medical Scientist Training Program and Meyerhoff Graduate Fellows Program, a nationally recognized program that supports underrepresented minorities in the sciences. The strength of our graduate training efforts, successes in recruitment, and the stable federal funding at the UMSOM suggest that continued funding for our program is well justified. With continued support, the faculty and students in the TPIMB can continue to spearhead the effort to integrate training in membrane, cell and systems biology at the UMSOM. |
0.972 |
2019 — 2021 | Trudeau, Matthew C | R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Conformational Dynamics of Herg Potassium Channels @ University of Maryland Baltimore Human ether á go-go related gene (hERG, KCNH2) potassium channels are of extraordinary clinical importance because they play a prominent role in heart where they generate a current that repolarizes cardiac action potentials. Mutations in hERG channels and inhibition by drugs cause a reduction in hERG and account for inherited and acquired forms of a type of heart disease known as long QT syndrome (LQTS) which emphasizes the importance of these channels in normal physiological function. The acquired form of LQT is due to the off-site effects of prescription drugs which inhibit hERG, and are a prevalent and serious clinical problem. hERG channels have highly specialized gating (opening and closing) properties that optimize them for their cellular roles in the heart and specialized subunit assembly properties that also control channel gating. The association of hERG with other regulatory or accessory proteins is also a major area of interest for understanding how hERG channels are regulated. The goal of the proposed experiments is to understand the molecular mechanisms that underlie these specializations and how they control hERG current. We will be testing recent structures showing direct N- and C-terminal domain interactions of hERG that we first showed using biochemical, electrophysiological and fluorescence measurements, and how these domain interactions control gating of the channels. Our approach is cutting-edge as we will use electrophysiological recordings to investigate channel conformational changes and fluorescence microscopy to study how structural interactions control channel gating and regulation. We will take advantage of non-canonical amino acid biology to introduce small probes to hERG and introduce metal binding sites at locations guided by structures and probe for movements with transition metal FRET and voltage. Completion of these studies will lead to a greater understanding of the basic mechanisms for hERG channel gating and insight into how intracellular domains of the channel regulate opening and closing. Our outcomes are anticipated to lead to rational biomedical strategies and new molecular target for the treatment of cardiac arrhythmias. |
0.972 |
2019 — 2021 | Trudeau, Matthew C | R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Regulatory and Functional Mechanisms in Herg Ion Channels @ University of Maryland Baltimore Human ether á go-go related gene (hERG) potassium channels are of extraordinary clinical importance. hERG channels play a prominent role in the heart by generating a current that repolarizes cardiac action potentials. Mutations in the hERG gene and inhibition of hERG channels by the off-target action of prescription drugs cause a reduction in hERG current that accounts for both inherited and acquired forms of long QT syndrome (LQTS), a predisposition to cardiac arrhythmias. The disease relevance of hERG emphasizes the importance of these channels in normal physiological function. hERG channels have highly specialized gating properties (opening and closing) that optimize them for their cellular roles in the heart and specialized subunit assembly properties that also control channel gating. hERG (also known as the primary isoform, hERG1a) associates with another `alpha' subunit isoform, hERG1b. The mechanisms of subunit association are a major area of interest for understanding how heteromeric hERG1a/hERG1b channels are regulated and gated. The goal of the proposed experiments is to understand the molecular mechanisms that underlie these specializations and how they control homomeric hERG1a and heteromeric hERG1a/hERG1b channels. We will examine hERG1a and hERG1b subunit protein-protein interactions using novel fluorescence methods and protein biochemistry assays. We will test recent structures of static N- and C-terminal domain interactions within hERG1a and test how these domain interactions control assembly and dynamically rearrange during channel gating. Our approach is cutting-edge as we will use electrophysiological recordings to investigate channel conformational changes and fluorescence microscopy to study how structural interactions control channel gating and regulation. We will take advantage of non-canonical amino acid biology to engineer small probes to hERG1a and introduce metal binding sites at locations guided by recent structures and test for movements with transition metal FRET and voltage. We will also use a functional toolbox of approaches to examine the structural and functional interactions of hERG1a and hERG1b subunits and the cellular role of disease-causing mutations in human induced pluripotent stem cell-derived cardiomyocytes, which have a robust cardiac IKr current formed by hERG1a and hERG1b channel subunits. Completion of these studies will lead to a greater understanding of the basic mechanisms for homomeric hERG1a and heteromeric hERGa1a/hERG1b channel gating, insight into how intracellular domains of the channels regulate the assembly of hERG1a and hERG1b subunits and how mutations perturb these interactions. Based on our deep understanding of mechanism, we have developed and will test hERG1a polypeptides that encode hERG1a functional domains for rescue of hERG1a and hERG1b LQTS mutant channels. Our outcomes are anticipated to lead to rational biomedical strategies to counteract or enhance the loss-of-function mutations in hERG1a and hERG1b subunits that cause arrhythmias. |
0.972 |